Prognostic and Immunological Role of THBS2 in Colorectal cancer

Biomed Res Int. 2021 Aug 21:2021:1124985. doi: 10.1155/2021/1124985. eCollection 2021.

Abstract

Objective: Thrombospondin 2 (THBS2) acts as oncogenic or tumor suppressive gene in diverse cancers. Here we studied the prognostic and immunological role of THBS2 in colorectal cancer (CRC) using bioinformatic analysis.

Methods: The genetic and protein expression of THBS2 in CRC were explored across several databases, including ONCOMINE, GEPIA2, TIMER 2.0, UALCAN and HPA databases. Correlation between THBS2 expression and clinical features in CRC was assessed using UALCAN tool. Prognostic analysis was performed using GEPIA2 and PrognoScan. Immune infiltration correlation with THBS2 in CRC was investigated with TIMER 2.0 and TISIDB. THBS2 binding and correlated genes were analyzed using String, GEPIA2, and TIMER 2.0.

Results: THBS2 was significantly higher in CRC across multiple databases. Age and histological subtype were correlated with THBS2 level. High THBS2 expression correlated with short overall and disease-free survival. THBS2 expression was positively correlated with immune infiltrates in CRC. Moreover, extracellular matrix structural constituent and organization, PI3K-Akt pathway, were involved in the functional mechanisms of THBS2.

Conclusions: THBS2 correlates with poor prognosis and immune infiltration in CRC. THBS2 may act as a prognostic and immunological biomarker for CRC.

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / immunology
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology*
  • Computational Biology / methods*
  • Databases, Genetic
  • Humans
  • Lymphocytes, Tumor-Infiltrating / immunology*
  • Prognosis
  • Survival Rate
  • Thrombospondins / immunology
  • Thrombospondins / metabolism*

Substances

  • Biomarkers, Tumor
  • Thrombospondins
  • thrombospondin 2